The Sage Group, Inc. today announced that Charles J. Casamento will join the firm as an Executive Director. “We are very pleased that Chuck has decided to join Sage. He will significantly expand our capability and expertise in serving the strategic transactional needs of our clients. Also, since Chuck resides in the Bay Area of Northern California, Sage will be able to be even more responsive to our clients on the west coast.” said Gordon Ramseier, another Executive Director of Sage. “Chuck’s outstanding track record as a life science entrepreneur and leader speaks for itself.”

Most recently, Mr. Casamento was President and CEO of Osteologix from October 2004 until April, 2007. Originally a private company founded in Copenhagen, Denmark, during his 29 months at Osteologix, Mr. Casamento commenced operations in the US, completed a financing with Rodman & Renshaw and Roth Capital Partners, took the company public, completed pre-clinical trials on the company’s lead product, completed phase I, initiated phase II clinical trials, and had the company granted a European patent for its lead product while gaining recognition on Wall Street as a viable public company. Osteologix was Mr. Casamento’s fourth start up company, all of which completed IPOs during his tenure.

During his career, Mr. Casamento has held a number of marketing, sales, finance and business development positions with Sandoz, Hoffmann-LaRoche, Johnson & Johnson and American Hospital Supply Corporation where he was Vice President of Business Development and Strategic Planning for the Critical Care Division.

He was Senior Vice President & General Manager for Pharmaceuticals and Biochemicals at Genzyme from 1985 through 1989 during which time Genzyme was taken public. In 1989 he co-founded and later took public, Interneuron Pharmaceuticals (Indevus) which eventually reached a $1.6 billion valuation. In 1993 Mr. Casamento joined RiboGene as Chairman, President and CEO. He took the Company public and completed several major corporate collaborations including a merger with another public corporation to form Questcor Pharmaceuticals, where he held roles as Chairman, CEO and President.

He is a Director and Board member at Cortex Pharmaceuticals and SuperGen, and he is a registered pharmacist in New York and New Jersey. A graduate of Fordham University in New York City and Iona College in New Rochelle, New York, Mr. Casamento has a degree in Pharmacy and an MBA.

“I am very excited about the opportunity that the Sage Group presents,” said Mr. Casamento. “The Sage Group Principals are a very well respected group of seasoned health care professionals who have a very impressive track record and great transactional experience. I am pleased to be one of them.”

About the Sage Group, Inc.

The Sage Group Inc. is a leader in the provision of strategic and transactional advice to health care companies in the pharmaceutical, diagnostics, medical device, biotechnology and life science fields. Sage currently maintains offices in Branchburg, NJ; Cambridge, England; and Yokohama, Japan. Since it’s founding in 1994, The Sage Group has served more than 200 clients in the US, Europe and Asia, and completed numerous transactions including divestitures, alliances, acquisitions and financings with values ranging from $5 million to $500 million. The establishment of operations in Europe and Japan over recent years allows its clients to reach out beyond their own regions and capture the potential of the global healthcare market.
The Sage Group is an organization of experienced and successful executives who are committed to the service of the very vital and dynamic health care industry and its investors.

The range of services offered includes:

• Mergers and Acquisitions
• Corporate Partnering, Licensing and Venturing
• Business Development Support & Planning
• Technology & Compound Brokerage
• Strategic Analysis and Development
• Valuations and Value-Enhancement Planning
• Forecasting, Risk Assessment and Due Diligence
• Commercial and Technical Assessment
• New Ventures

The Sage Group's Principals, each an Executive Director, have been Founders, Chairmen, Presidents, CEO's and COO's of a number of emerging health care companies. These Principals have also held senior level management positions in large multi-national organizations. In addition to their management backgrounds, The Sage Group's Principals also have extensive experience in providing professional management consulting services to healthcare industry clients. All these experiences are being applied by the Sage Group to assist industry participants in these challenging times.
Sage Group can be contacted at any of the offices shown below:

US Corporate Office European Corporate Office Japanese Corporate Office

Sage Group Inc.
3322 Route 22 West
Building 2, Suite 201
Branchburg, NJ 08876 US
Attn: Wayne Pambianchi
Phone: 908-231-9644
Fax: 908-231-9692
Email: wpambianch@aol.com
wbmcdonald@aol.com

Sage Healthcare Ltd.
Church Street Barns
Great Shelford
Cambridge CB2 5EL UK
Attn: Dr. Bill Mason
Phone: 44 (0) 1223 844128
Fax: 44 (0) 1223 847871
Email: wtm@sagehealthcare.com
Corporate Website:
http://www.sagehealthcare.com

Sage Japan Inc.
3-5-9 Shimoda-cho
Kohoku-ku
Yokohama
223-0064 Japan
Attn.: Yoshihiro Mizuta
Phone: 81-45-561-3717
Fax: 81-45-561-3743
Email: ymizuta@d03.itscom.net